CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference

31 3 2025 13:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

31 3 2025 09:28:38 提供 NetDania Notify

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

20 3 2025 04:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 3 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

17 3 2025 05:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Participate in March Investor Conferences

03 3 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update

27 2 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 2 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

13 2 2025 13:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

12 2 2025 06:45:01 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

11 2 2025 11:34:09 提供 NetDania Notify

Cytokinetics Names Robert E. Landry to Board of Directors

11 2 2025 04:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

10 2 2025 06:56:36 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

07 2 2025 07:17:25 提供 NetDania Notify

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05 2 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 2 2025 13:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program

30 1 2025 04:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction

21 1 2025 04:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

13 1 2025 11:43:22 提供 NetDania Notify

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

13 1 2025 04:30:00 提供 Nasdaq GlobeNewswire